Koenraad F van der Sluijs
Overview
Explore the profile of Koenraad F van der Sluijs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
1111
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Someren Greve F, van der Sluijs K, Tuip A, Schultz M, de Jong M, Juffermans N
J Med Virol
. 2018 May;
90(9):1431-1437.
PMID: 29718555
Secondary bacterial pneumonia is a frequent complication of influenza, associated with high morbidity and mortality. We hypothesized that treatment with neutralizing influenza A antibody AT10_002 protects against severe secondary pneumococcal...
2.
van Someren Greve F, Juffermans N, Bos L, Binnekade J, Braber A, Cremer O, et al.
Crit Care Med
. 2017 Oct;
46(1):29-36.
PMID: 28991822
Objectives: The presence of respiratory viruses and the association with outcomes were assessed in invasively ventilated ICU patients, stratified by admission diagnosis. Design: Prospective observational study. Setting: Five ICUs in...
3.
Kuipers M, Aslami H, Tuinman P, Tuip-de Boer A, Jongsma G, van der Sluijs K, et al.
Intensive Care Med Exp
. 2015 Jul;
2(1):22.
PMID: 26215707
Background: Mechanical ventilation (MV) can cause ventilator-induced lung injury (VILI). The innate immune response mediates this iatrogenic inflammatory condition. The receptor for advanced glycation end products (RAGE) is a multiligand...
4.
Fens N, van der Sluijs K, van de Pol M, Dijkhuis A, Smids B, van der Zee J, et al.
Am J Respir Crit Care Med
. 2015 May;
191(9):1086-8.
PMID: 25932767
No abstract available.
5.
Wagner K, Kwakkenbos M, Claassen Y, Maijoor K, Bohne M, van der Sluijs K, et al.
Proc Natl Acad Sci U S A
. 2014 Nov;
111(47):16820-5.
PMID: 25385586
Bispecific antibodies have therapeutic potential by expanding the functions of conventional antibodies. Many different formats of bispecific antibodies have meanwhile been developed. Most are genetic modifications of the antibody backbone...
6.
El-Zaatari M, Chang Y, Zhang M, Franz M, Shreiner A, McDermott A, et al.
J Immunol
. 2014 Jun;
193(2):807-16.
PMID: 24935925
The interplay between Clostridium difficile and the host's metabolome is believed to influence the severity of infection. However, the mechanism for this phenomenon remains unclear. In this study, we model...
7.
Glas G, Muller J, Binnekade J, Cleffken B, Colpaert K, Dixon B, et al.
Trials
. 2014 Mar;
15:91.
PMID: 24661817
Background: Pulmonary coagulopathy is a hallmark of lung injury following inhalation trauma. Locally applied heparin attenuates lung injury in animal models of smoke inhalation. Whether local treatment with heparin benefits...
8.
Majoor C, van de Pol M, Kamphuisen P, Meijers J, Molenkamp R, Wolthers K, et al.
Respir Res
. 2014 Feb;
15:14.
PMID: 24502801
Background: Asthma exacerbations are frequently triggered by rhinovirus infections. Both asthma and respiratory tract infection can activate haemostasis. Therefore we hypothesized that experimental rhinovirus-16 infection and asthmatic airway inflammation act...
9.
Muller M, Tuinman P, van der Sluijs K, Boon L, Roelofs J, Vroom M, et al.
Transfusion
. 2013 Sep;
54(4):996-1001.
PMID: 24032748
Background: Transfusion-related acute lung injury (TRALI) is the leading cause of transfusion-related morbidity and mortality. Anecdotally, TRALI patients have been treated with corticosteroids. However, evidence for its therapeutic rationale in...
10.
van der Sluijs K, van de Pol M, Kulik W, Dijkhuis A, Smids B, van Eijk H, et al.
Thorax
. 2013 Jul;
68(12):1122-30.
PMID: 23882022
Background: Patients with allergic asthma have exacerbations which are frequently caused by rhinovirus infection. The antiviral tryptophan-catabolising enzyme indoleamine 2,3-dioxygenase (IDO) is induced by interferon-γ and suppressed by Th2 mediators...